Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European journal of health economics
1. Verfasser: Michailov, Galin V. (VerfasserIn)
Weitere Verfasser: Davies, Glenn M. (VerfasserIn), Krobot, Karl J. (VerfasserIn)
Format: UnknownFormat
Sprache:eng
Veröffentlicht: 2012
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Titel Jahr Verfasser
Incorporating self-reported health measures in risk equalization through constrained regression 2020 Withagen-Koster, A. A.
Cost of poor health to the labour market returns to education in Australia : another pathway for socio-economic inequality 2020 Doan, Tinh
Incidence and costs of hospitalized adult influenza patients in The Netherlands : a retrospective observational study 2020 Marbus, Sierk D.
Improving access to services for psychotic patients : does implementing a waiting time target make a difference 2020 Kreutzberg, Anika
The Amsterdam Wrist Rules : how much money can they save? 2020 Mulders, Marjolein A. M.
Reply to the comment on "Trends in rates of orthopedic surgery in Germany: the good, the bad, the ugly." 2020 Baier, Natalie
A novel method for predicting the budget impact of innovative medicines : validation study for oncolytics 2020 Geenen, Joost W.
Health-related quality of life in elderly people with hypertension and the estimation of minimally important difference using EQ-5D-5L in Hong Kong SAR, China 2020 Wong, Eliza Lai Yi
Once we have it, will we use it? : A European survey on willingness to be vaccinated against COVID-19 2020 Neumann-Böhme, Sebastian
Impacts of air pollution on health : evidence from longitudinal cohort data of patients with cardiovascular diseases 2020 Afoakwah, Clifford
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN) 2020 Jongeneel, Gabrielle
EQ-5D-5L Bulgarian population norms 2020 Encheva, Marta
Costs and where to find them : identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy 2020 Pöhlmann, J.
Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock : the CULPRIT-SHOCK trial 2020 Robles-Zurita, Jose-Antonio
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? : A review of national health technology assessment (HTA) guidelines 2020 Kennedy-Martin, Matthew
The impact of the diabetes management incentive on diabetes-related services : evidence from Ontario, Canada 2020 Thavam, Thaksha
General practitioners' income and activity : the impact of multi-professional group practice in France 2020 Cassou, Matthieu
Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas 2020 Xu, Richard Huan
Cost-consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain : an analysis based on the Salford Lung Study in asthma 2020 Vallejo-Aparicio, Laura Amanda
Speeding up the clinical pathways by accessing emergency departments 2020 Levaggi, Rosella
Alle Artikel auflisten